These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8622011)

  • 1. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Celik I; Kars A; Ozyar E; Tekuzman G; Atahan L; Firat D
    J Clin Oncol; 1996 Mar; 14(3):1043-4. PubMed ID: 8622011
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
    J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Schwarz LR
    Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?
    Licitra L; Bossi P; Locati L; Zunino F
    J Clin Oncol; 2004 Jan; 22(2):377; author reply 377-8. PubMed ID: 14722048
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.
    Dechaphunkul T; Pruegsanusak K; Sangthawan D; Sunpaweravong P
    Head Neck Oncol; 2011 Jun; 3():30. PubMed ID: 21639934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
    Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
    Rodriguez-Galindo C; Wofford M; Castleberry RP; Swanson GP; London WB; Fontanesi J; Pappo AS; Douglass EC
    Cancer; 2005 Feb; 103(4):850-7. PubMed ID: 15641027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
    Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
    Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
    J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
    Wu SX; Cui TT; Zhao C; Pan JJ; Xu BY; Tian Y; Cui NJ
    Radiother Oncol; 2010 Oct; 97(1):113-8. PubMed ID: 20826029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe reaction after chemoradiotherapy of nasopharyngeal carcinoma with collagen disease.
    Hareyama M; Nagakura H; Tamakawa M; Hyodo K; Asakura K; Horikoshi T; Oouchi A; Shido M; Morita K
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):971. PubMed ID: 7591915
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
    Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
    Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
    Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
    Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: a preliminary report of phase II study.
    Fuwa N; Kano M; Toita T; Shikama N; Kodaira T; Matsumoto A; Kamata M; Furutani K; Tatibana H
    Radiother Oncol; 2001 Dec; 61(3):257-60. PubMed ID: 11730994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.